platinum has been researched along with Nasopharyngeal Carcinoma in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 9 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Ding, SR; Glorieux, C; Huang, P; Huang, ZL; Li, H; Li, XH; Liu, SR; Tao, YL; Wang, GN; Wang, HB; Wei, YH; Wu, YF; Xia, YF; Zheng, SH | 1 |
| But, B; Chan, ATC; Chappell, RJ; Cheng, AC; Choi, CW; Kwong, DLW; Lee, AWM; Lee, S; Lu, TX; Ng, WT; Ngan, RKC; Tung, S; Wong, F; Yiu, H; Yuen, KT | 1 |
| Kang, M; Li, C; Li, Z; Liu, T; Song, J; Yang, D; Zhou, L; Zhou, Z | 1 |
| Colevas, AD; Coty, J; Hara, W; Jun, M; Le, QT; Lira, R; Lu, R; McMillan, A; Pinto, H; Quon, A; Winters, E | 1 |
| Cai, ZC; Chen, X; Deng, Y; Guo, X; Huang, HY; Huang, YY; Liang, CX; Lv, X; Qiang, MY; Zhan, ZJ; Zhang, LL; Zhou, JY | 1 |
| Cai, XY; Chen, QY; Deng, SW; Guo, L; Guo, SS; Jia, GD; Li, SC; Li, XY; Li, YF; Lin, DF; Liu, LT; Liu, SL; Luo, DH; Lv, XF; Mai, HQ; Sun, XS; Tang, LQ; Xie, SY; Yuan, L; Zeng, MS | 1 |
| Cao, Y; Hua, F; Luo, J; Wang, D; Wang, X; Xiao, W | 1 |
| Ahmed, SA; Al-Rajhi, N; Elhassan, T; Ghebeh, H; Khoja, HA; Mohammed, SF; Soudy, H | 1 |
| Cavalieri, S; Licitra, L | 1 |
| Blanchard, P; Tao, Y | 1 |
| Chen, X; Feng, J; Guan, X; Hong, Y; Song, H; Ye, J; You, X; Zheng, P | 1 |
| Dong, M; Gui, L; He, X; Hu, S; Jia, B; Liu, P; Qin, Y; Yang, J; Yang, S; Zhang, C; Zhou, S | 1 |
3 review(s) available for platinum and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Comparing the efficacy and safety of cisplatin and other platinum-based chemotherapies in locally advanced nasopharyngeal carcinoma: a systematic review and meta-analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Humans; Induction Chemotherapy; Leukopenia; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Platinum | 2022 |
Efficacy and safety of PD-1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens: a systematic review and meta-analysis.
Topics: B7-H1 Antigen; Humans; Immune Checkpoint Inhibitors; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Platinum | 2023 |
Concurrent chemoradiotherapy comparison of taxanes and platinum versus 5-fluorouracil and platinum in nasopharyngeal carcinoma treatment.
Topics: Carcinoma; Chemoradiotherapy; Fluorouracil; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Platinum; Taxoids; Treatment Outcome | 2014 |
1 trial(s) available for platinum and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Camrelizumab combined with apatinib in patients with first-line platinum-resistant or PD-1 inhibitor resistant recurrent/metastatic nasopharyngeal carcinoma: a single-arm, phase 2 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Immune Checkpoint Inhibitors; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Platinum | 2023 |
8 other study(ies) available for platinum and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Treatment and Survival Outcomes Associated With Platinum Plus Low-Dose, Long-term Fluorouracil for Metastatic Nasopharyngeal Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; China; Cohort Studies; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Platinum; Retrospective Studies; Survival Analysis; Treatment Outcome | 2021 |
Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemotherapy, Adjuvant; Cisplatin; Fluorouracil; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Platinum; Radiotherapy, Intensity-Modulated | 2022 |
In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Chemoradiotherapy; Cisplatin; Docetaxel; Fluorouracil; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Platinum | 2023 |
Incidence, consequences, and predictors of serious chemotherapy-induced thrombocytopenia in nasopharyngeal carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Humans; Incidence; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Platinum; Prognosis; Retrospective Studies; Thrombocytopenia | 2023 |
CD3+T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma.
Topics: Adolescent; Adult; Aged; B7-H1 Antigen; CD3 Complex; Chemoradiotherapy; Female; Humans; Lymphocytes, Tumor-Infiltrating; Male; Middle Aged; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Platinum; Prognosis; Retrospective Studies; Survival Analysis; T-Lymphocyte Subsets; Treatment Outcome; Young Adult | 2020 |
Next generation platinum salt in nasopharygeal carcinoma.
Topics: Carcinoma; Chemoradiotherapy; Cisplatin; Cyclobutanes; Fluorouracil; Humans; Induction Chemotherapy; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Platinum | 2021 |
Nedaplatin in nasopharyngeal cancer: the rebirth of platinum salts?
Topics: Antineoplastic Agents; Chemoradiotherapy; Cisplatin; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organoplatinum Compounds; Platinum; Salts | 2018 |
[Efficacy and safety evaluation of gemcitabine combined with ifosfamide in patients with advanced nasopharyngeal carcinoma after failure of platinum-based chemotherapy].
Topics: Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Deoxycytidine; Disease-Free Survival; Gemcitabine; Humans; Ifosfamide; Induction Chemotherapy; Kaplan-Meier Estimate; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neutropenia; Platinum; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia; Treatment Failure | 2015 |